These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 30882398)

  • 1. Salinomycin reduces epithelial-mesenchymal transition-mediated multidrug resistance by modifying long noncoding RNA HOTTIP expression in gastric cancer cells.
    Mao Z; Wu Y; Zhou J; Xing C
    Anticancer Drugs; 2019 Oct; 30(9):892-899. PubMed ID: 30882398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
    Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
    Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated IL-24 expression enhances the chemosensitivity of multidrug-resistantgastric cancer cells to cisplatin.
    Mao Z; Bian G; Sheng W; He S; Yang J; Dong X
    Oncol Rep; 2013 Nov; 30(5):2288-96. PubMed ID: 23982423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance.
    Tsou SH; Chen TM; Hsiao HT; Chen YH
    PLoS One; 2015; 10(1):e0116747. PubMed ID: 25635866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
    Zhang XW; Bu P; Liu L; Zhang XZ; Li J
    Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells.
    Lan WG; Xu DH; Xu C; Ding CL; Ning FL; Zhou YL; Ma LB; Liu CM; Han X
    Oncol Rep; 2016 Jul; 36(1):263-70. PubMed ID: 27121324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
    Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
    Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated ING4 expression reduces multidrug resistance of human gastric carcinoma cells in vitro and in vivo.
    Mao ZL; He SB; Sheng WH; Dong XQ; Yang JC
    Oncol Rep; 2013 Nov; 30(5):2187-94. PubMed ID: 23969950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of long non-coding RNA GHET1 promotes the development of multidrug resistance in gastric cancer cells.
    Zhang X; Bo P; Liu L; Zhang X; Li J
    Biomed Pharmacother; 2017 Aug; 92():580-585. PubMed ID: 28578256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DJ-1 is involved in the multidrug resistance of SGC7901 gastric cancer cells through PTEN/PI3K/Akt/Nrf2 pathway.
    Qiu L; Ma Z; Li X; Deng Y; Duan G; Zhao LE; Xu X; Xiao L; Liu H; Zhu Z; Chen H
    Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1202-1214. PubMed ID: 33079995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AP-2α reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway.
    Lian W; Zhang L; Yang L; Chen W
    Apoptosis; 2017 Jul; 22(7):933-941. PubMed ID: 28439677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of multidrug resistance in gastric cancer cells by E2F-1 downregulation in vitro and in vivo.
    Yan LH; Wang XT; Yang J; Kong FB; Lian C; Wei WY; Luo W; Xie YB; Xiao Q
    J Cell Biochem; 2014 Jan; 115(1):34-41. PubMed ID: 24038122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
    Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
    Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-Coding RNA (LncRNA) Urothelial Carcinoma Associated 1 (UCA1) Increases Multi-Drug Resistance of Gastric Cancer via Downregulating miR-27b.
    Fang Q; Chen X; Zhi X
    Med Sci Monit; 2016 Oct; 22():3506-3513. PubMed ID: 27694794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen reduces P-gp-mediated multidrug resistance via inhibiting the PI3K/Akt signaling pathway in ER-negative human gastric cancer cells.
    Mao Z; Zhou J; Luan J; Sheng W; Shen X; Dong X
    Biomed Pharmacother; 2014 Mar; 68(2):179-83. PubMed ID: 24184201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells.
    Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P
    Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer.
    Xu J; Liu D; Niu H; Zhu G; Xu Y; Ye D; Li J; Zhang Q
    J Exp Clin Cancer Res; 2017 Jan; 36(1):19. PubMed ID: 28126034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NIK‑ and IKKβ‑binding protein contributes to gastric cancer chemoresistance by promoting epithelial‑mesenchymal transition through the NF‑κB signaling pathway.
    Fu ZH; Liu SQ; Qin MB; Huang JA; Xu CY; Wu WH; Zhu LY; Qin N; Lai MY
    Oncol Rep; 2018 Jun; 39(6):2721-2730. PubMed ID: 29620292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyphyllin I inhibits growth and invasion of cisplatin-resistant gastric cancer cells by partially inhibiting CIP2A/PP2A/Akt signaling axis.
    Zhang Y; Huang P; Liu X; Xiang Y; Zhang T; Wu Y; Xu J; Sun Z; Zhen W; Zhang L; Si Y; Liu Y
    J Pharmacol Sci; 2018 Jul; 137(3):305-312. PubMed ID: 30119963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.